相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。When Clinical Trials Fail to Address Treatment Gaps: The Failure of Niacin-Laropiprant to Reduce Cardiovascular Events
Robert S. Rosenson et al.
Current Atherosclerosis Reports (2013)
HPS2-THRIVE randomized placebo-controlled trial in 25 673 high-risk patients of ER niacin/laropiprant: trial design, pre-specified muscle and liver outcomes, and reasons for stopping study treatment
Richard Haynes et al.
EUROPEAN HEART JOURNAL (2013)
Lipid-altering efficacy and safety profile of co-administered extended release niacin/laropiprant and simvastatin versus atorvastatin in patients with mixed hyperlipidemia
Fabian Chen et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2013)
Nicotinic acid and DP1 blockade: studies in mouse models of atherosclerosis
Alison M. Strack et al.
JOURNAL OF LIPID RESEARCH (2013)
Anti-inflammatory role of PGD2 in acute lung inflammation and therapeutic application of its signal enhancement
Takahisa Murata et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Role of prostaglandin D2 and the autonomic nervous system in niacin-induced flushing
Henri K. Parson et al.
JOURNAL OF DIABETES (2013)
Statins and Risk of New-Onset Diabetes Mellitus
Ravi V. Shah et al.
CIRCULATION (2012)
Niacin and biosynthesis of PGD2 by platelet COX-1 in mice and humans
Wen-Liang Song et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Effects of coadministered extended-release niacin/laropiprant and simvastatin on lipoprotein subclasses in patients with dyslipidemia
Christie Ballantyne et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2012)
Niacin and Statin Combination Therapy for Atherosclerosis Regression and Prevention of Cardiovascular Disease Events Reconciling the AIM-HIGH (Atherothrombosis Intervention in Metabolic Syndrome With Low HDL/High Triglycerides: Impact on Global Health Outcomes) Trial With Previous Surrogate Endpoint Trials
Erin D. Michos et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2012)
Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study
Benjamin F. Voight et al.
LANCET (2012)
The not-so-simple HDL story Is it time to revise the HDL cholesterol hypothesis?
Daniel J. Rader et al.
NATURE MEDICINE (2012)
Effects of Dalcetrapib in Patients with a Recent Acute Coronary Syndrome
Gregory G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
It Ain't Over 'Til the Fat Lady Sings
Stefan Offermanns
SCIENCE TRANSLATIONAL MEDICINE (2012)
Niacin Lipid Efficacy Is Independent of Both the Niacin Receptor GPR109A and Free Fatty Acid Suppression
Brett Lauring et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Extended-release niacin/laropiprant lipid-altering consistency across patient subgroups
H. Bays et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Nicotinic Acid Has Anti-atherogenic and Anti-inflammatory Properties on Advanced Atherosclerotic Lesions Independent of its Lipid-modifying Capabilities
Eva Holzhaeuser et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2011)
Nicotinic acid inhibits progression of atherosclerosis in mice through its receptor GPR109A expressed by immune cells
Martina Lukasova et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Novel HDL-directed pharmacotherapeutic strategies
Emil M. Degoma et al.
NATURE REVIEWS CARDIOLOGY (2011)
Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis
Amit V. Khera et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy
William E. Boden et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Lipoprotein(a) and risk of myocardial infarction - genetic epidemiologic evidence of causality
Pia R. Kamstrup et al.
SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION (2011)
GLUCOSE TOLERANCE AND PLASMA INSULIN IN MAN DURING ACUTE AND CHRONIC ADMINISTRATION OF NICOTINIC ACID
Tatu A. Miettinen et al.
ACTA MEDICA SCANDINAVICA (2010)
Cholesterol Efflux Potential and Antiinflammatory Properties of High-Density Lipoprotein After Treatment With Niacin or Anacetrapib
Laurent Yvan-Charvet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Evidence That Niacin Inhibits Acute Vascular Inflammation and Improves Endothelial Dysfunction Independent of Changes in Plasma Lipids
Ben J. Wu et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2010)
Regulation of Hepatic ApoC3 Expression by PGC-1β Mediates Hypolipidemic Effect of Nicotinic Acid
Carlos Hemandez et al.
CELL METABOLISM (2010)
Lipoprotein(a) as a cardiovascular risk factor: current status
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2010)
Seeing red: flushing out instigators of niacin-associated skin toxicity
Richard L. Dunbar et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Nicotinic acid- and monomethyl fumarate-induced flushing involves GPR109A expressed by keratinocytes and COX-2-dependent prostanoid formation in mice
Julien Hanson et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Efficacy and tolerability of extended-release niacin/laropiprant in dyslipidemic patients with metabolic syndrome
Harold E. Bays et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2010)
Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials
C. Baigent et al.
LANCET (2010)
Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials
Naveed Sattar et al.
LANCET (2010)
Flushing Profile of Extended-Release Niacin/Laropiprant Versus Gradually Titrated Niacin Extended-Release in Patients With Dyslipidemia With and Without Ischemic Cardiovascular Disease
Dorbie Maccubbin et al.
AMERICAN JOURNAL OF CARDIOLOGY (2009)
Niacin stimulates adiponectin secretion through the GPR109A receptor
Eric P. Plaisance et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2009)
Effects of Niacin on Cell Adhesion and Early Atherogenesis: Biochemical and Functional Findings in Endothelial Cells
Subramaniam Tavintharan et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2009)
Niacin for dairy cattle: a review
Inka-Donata Niehoff et al.
BRITISH JOURNAL OF NUTRITION (2009)
Flushing Profile of Extended-Release Niacin/Laropiprant at Initiation of Therapy in Asian Lipid Clinic Patients
Debra Kush et al.
CARDIOLOGY (2009)
β-Arrestin1 mediates nicotinic acid-induced flushing, but not its antilipolytic effect, in mice
Robert W. Walters et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Lipid-modifying efficacy of extended release niacin/laropiprant in Asian patients with primary hypercholesterolemia or mixed hyperlipidemia
Debra Kush et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2009)
Laropiprant in Combination With Extended-Release Niacin Does Not Alter Urine 11-Dehydrothromboxane B2, a Marker of In Vivo Platelet Function, in Healthy, Hypercholesterolemic, and Diabetic Subjects
Brett Lauring et al.
JOURNAL OF CLINICAL PHARMACOLOGY (2009)
Effects of High-Dose Modified-Release Nicotinic Acid on Atherosclerosis and Vascular Function A Randomized, Placebo-Controlled, Magnetic Resonance Imaging Study
Justin M. S. Lee et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Extended-Release Niacin or Ezetimibe and Carotid Intima-Media Thickness
Allen J. Taylor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Effects of laropiprant on nicotinic acid-induced flushing in patients with dyslipidemia
John F. Paolini et al.
AMERICAN JOURNAL OF CARDIOLOGY (2008)
Nicotinic acid: Pharmacological effects and mechanisms of action
Andreas Gille et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY (2008)
Extended-release niacin alters the metabolism of plasma apolipoprotein (Apo) A-I and apoB-containing lipoproteins
Stefania Lamon-Fava et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Preferential increase in high-molecular weight adiponectin after niacin
Sabine Westphal et al.
ATHEROSCLEROSIS (2008)
Lipid-modifying efficacy and tolerability of extended-release niacin/laropiprant in patients with primary hypercholesterolaemia or mixed dyslipidaemia
D. Maccubbin et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Effects of a niacin receptor partial agonist, MK-0354, on plasma free fatty acids, lipids, and cutaneous flushing in humans
Eseng Lai et al.
JOURNAL OF CLINICAL LIPIDOLOGY (2008)
Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein
Paul M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Hematopoietic prostaglandin D2 synthase controls the onset and resolution of acute inflammation through PGD2 and 15-deoxyΔ12-14 PGJ2
Ravindra Rajakariar et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Lipoprotein (a) and stroke - A meta-analysis of observational studies
Barbara Smolders et al.
STROKE (2007)
Suppression of niacin-induced vasodilation with an antagonist to prostaglandin D2 receptor subtype 1
E. Lai et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2007)
Nicotinic acid receptor subtypes and their ligands
Willem Soudijn et al.
MEDICINAL RESEARCH REVIEWS (2007)
Anti-inflammatory effect is an important property of niacin on atherosclerosis beyond its lipid-altering effects
Bi-lian Yu et al.
MEDICAL HYPOTHESES (2007)
The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3
Allen J. Taylor et al.
CURRENT MEDICAL RESEARCH AND OPINION (2006)
Small-molecule compounds that modulate lipolysis in adipose tissue: Targeting strategies and molecular classes
Minghan Wang et al.
CHEMISTRY & BIOLOGY (2006)
Antagonism of the prostaglandin D2 receptor 1 suppresses nicotinic acid-induced vasodilation in mice and humans
K Cheng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Niacin induces PPARγ expression and transcriptional activation in macrophages via HM74 and HM74a-mediated induction of prostaglandin synthesis pathways
HJ Knowles et al.
BIOCHEMICAL PHARMACOLOGY (2006)
1-Alkyl-benzotriazole-5-carboxylic acids are highly selective agonists of the human orphan G-protein-coupled receptor GPR109b
G Semple et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
GPR109A (PUMA-G/HM74A) mediates nicotinic acid-induced flushing
Z Benyó et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review
LA Carlson
JOURNAL OF INTERNAL MEDICINE (2005)
Efficacy and safety of high-density lipoprotein cholesterol-increasing compounds - A meta-analysis of randomized controlled trials
RS Birjmohun et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Benefits of niacin by glycemic status in patients with healed myocardial infarction (from the coronary drug project)
PL Canner et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
New perspectives on the use of niacin in the treatment of lipid disorders
J McKenney
ARCHIVES OF INTERNAL MEDICINE (2004)
Stimulation of CD36 and the key effector of reverse cholesterol transport ATP-binding cassette A1 in monocytoid cells by niacin
T Rubic et al.
BIOCHEMICAL PHARMACOLOGY (2004)
Niacin noncompetitively inhibits DGAT2 but not DGAT1 activity in HepG2 cells
SH Ganji et al.
JOURNAL OF LIPID RESEARCH (2004)
Arterial biology for the investigation of the treatment effects of reducing cholesterol (ARBITER) 2 - A double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with statins
AJ Taylor et al.
CIRCULATION (2004)
Lipoprotein(a) An elusive cardiovascular risk factor
L Berglund et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)
Niacin therapy in atherosclerosis
CD Meyers et al.
CURRENT OPINION IN LIPIDOLOGY (2004)
Pharmacological modulation of cholesteryl ester transfer protein, a new therapeutic target in atherogenic dyslipidemia
W Le Goff et al.
PHARMACOLOGY & THERAPEUTICS (2004)
Effect of recombinant ApoA-I Milano on coronary atherosclerosis in patients with acute coronary syndromes - A randomized controlled trial
SE Nissen et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Pyrazole derivatives as partial Agonists for the nicotinic acid receptor
T van Herk et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Overexpression of apolipoprotein A-I promotes reverse transport of cholesterol from macrophages to feces in vivo
YZ Zhang et al.
CIRCULATION (2003)
Nicotinic acid-induced insulin resistance is related to increased circulating fatty acids and fat oxidation but not muscle lipid content
AM Poynten et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2003)
Statin-associated myopathy
PD Thompson et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2003)
Molecular identification of nicotinic acid receptor
T Soga et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Molecular identification of high and low affinity receptors for nicotinic acid
A Wise et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
PUMA-G and HM74 are receptors for nicotinic acid and mediate its anti-lipolytic effect
S Tunaru et al.
NATURE MEDICINE (2003)
Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease
BG Brown et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Effect of niacin, warfarin, and antioxidant therapy on coagulation parameters in patients with peripheral arterial disease in the Arterial Disease Multiple Intervention Trial (ADMIT)
CM Chesney et al.
AMERICAN HEART JOURNAL (2000)
Lipoprotein(a) and coronary heart disease - Meta-analysis of prospective studies
J Danesh et al.
CIRCULATION (2000)
分享论文
